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A B S T R A C T
Gulf War Illness (GWI), affecting 30% of veterans from the 1991 Gulf War (GW), is a multi-symptom illness with
features similar to those of patients with autoimmune diseases. The objective of the current work is to determine
if exposure to GW-related pesticides, such as permethrin (PER), activates peripheral and central nervous system
(CNS) adaptive immune responses. In the current study, we focused on a PER metabolite, 3-phenoxybenzoic acid
(3-PBA), as this is a common metabolite previously shown to form adducts with endogenous proteins. We ob-
served the presence of 3-PBA and 3-PBA modified lysine of protein peptides in the brain, blood and liver of
pyridostigmine bromide (PB) and PER (PB+PER) exposed mice at acute and chronic post-exposure timepoints.
We tested whether 3-PBA-haptenated albumin (3-PBA-albumin) can activate immune cells since it is known that
chemically haptenated proteins can stimulate immune responses. We detected autoantibodies against 3-PBA-
albumin in plasma from PB+PER exposed mice and veterans with GWI at chronic post-exposure timepoints. We
also observed that in vitro treatment of blood with 3-PBA-albumin resulted in the activation of B- and T-helper
lymphocytes and that these immune cells were also increased in blood of PB+PER exposed mice and veterans
with GWI. These immune changes corresponded with elevated levels of infiltrating monocytes in the brain and
blood of PB+PER exposed mice which coincided with alterations in the markers of blood-brain barrier dis-
ruption, brain macrophages and neuroinflammation. These studies suggest that pesticide exposure associated
with GWI may have resulted in the activation of the peripheral and CNS adaptive immune responses, possibly
contributing to an autoimmune-type phenotype in veterans with GWI.
1. Introduction
Gulf War Illness (GWI) affects approximately 30% of the US military
personnel who were deployed to the 1991 Gulf War (GW) (White et al.,
2016). Nearly 30 years later, GW veterans continue to experience de-
bilitating symptoms such as pain, fatigue and memory problems.
Clinical studies suggest that immune dysfunction and chronic in-
flammation are among the key causes of the symptoms experienced by
ill GW veterans (White et al., 2016). Studies using the rodent models of
GWI implicate both the central nervous system (CNS) and peripheral
immune system in contributing to the pathogenesis of this illness (Koo
et al., 2018). However, a better understanding of these immune
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responses in GWI would further contribute towards the development of
biomarkers and therapies for the CNS symptoms and pathology of GWI.
While no single etiological factor has been definitively linked to
GWI (Binns et al., 2008), reports compiled by the Research Advisory
Committee (RAC) on GWI based on self-reported systematic retro-
spective data collection from GW veterans implicate exposure to GW
chemicals, such as an anti-nerve agent pyridostigmine bromide (PB), an
irreversible acetylcholinesterase (AChE) inhibitor and pesticides like
permethrin (PER), in the pathogenesis of GWI. It is now well established
that pesticide exposure played a significant role in the manifestation of
GWI (Binns et al., 2008; Sullivan et al., 2018). According to Department
of Defense (DoD) reports, 62% of the ground troops reported being
exposed to any pesticides (Winkenwerder, 2003). Among these, 44%
were pesticide sprays that contained pyrethroids, such as PER (Binns
et al., 2008). Exposure to pesticides in humans can be associated with
autoimmune disorders (Thrasher et al., 1993). Several case reports
documented that acute pyrethroid intoxication in humans is associated
with an autoimmune clinical phenotype, including disorders like
scleroderma and myasthenia-like syndromes (Müller-Mohnssen, 1999;
Proudfoot, 2005; Gangemi et al., 2016). The most compelling evidence
for autoimmune abnormalities in GWI comes from studies showing
increases in immunoglobulin G (IgG) and T- and B-cells in the blood of
veterans with GWI compared to healthy GW veterans (Vojdani and
Thrasher, 2004), and is supported by a study showing elevated auto-
antibodies against brain-specific proteins, such as glial fibrillary acidic
protein (GFAP) and tau in blood from veterans with GWI (Abou-Donia
et al., 2017).
Low molecular weight chemicals can form adducts with endogenous
proteins, and these chemically modified proteins can elicit an adaptive
immune response (Warrington, 2012). Studies have shown that a 3-
phenoxybenzoic acid (3-PBA) is a common metabolite of PER, which is
generated by esterase cleavage followed by enzymatic oxidation (Noort
et al., 2008). It is shown that 3-PBA can undergo glucuronidation in the
liver for excretion in urine to form 1-O-(3-phenoxybenzoyl)-ß-D-glu-
copyranuronate (Glu-3-PBA) (Noort et al., 2008). This Glu-3-PBA has
been shown to further react to form an amide with lysine in proteins
(Noort et al., 2008). Others have shown that chemically-haptenated
proteins can reach the lymphatic system where they encounter immune
cells that are involved in antigen presentation to T- and B-cells
(Karlsson et al., 2018). These studies suggest a role of haptenated
proteins in promoting autoimmune responses. As such, an activation of
autoimmune responses in GWI could be downstream of PER exposure
that occurred during the GW conflict.
Autoantibodies against brain proteins are a part of a continuum of
many autoimmune disorders (Diamond et al., 2013). An example of this
is Sydenham’s chorea, a neurological manifestation of rheumatic fever
where peripheral autoantibodies against Group A β-hemolytic strepto-
coccus cross-reacts with neuronal proteins (Diamond et al., 2013). In
systemic lupus erythematosus (SLE), peripherally generated anti-DNA
antibodies enter the brain and cross-react with N-methyl-D-aspartate
(NMDA) receptors (Omdal et al., 2005). In other autoimmune disorders,
such as multiple sclerosis (MS), studies suggest that a breach in the
blood-brain barrier (BBB) allows CNS proteins to leak into the per-
iphery where immune cells first encounter them. Alternatively, these
immune cells can gain antigen experience within the cervical lymph
nodes where CNS antigens drain (Stern et al., 2014). While the exact
mechanisms behind brain and peripheral immune cross-talk remain
unknown in GWI, the presence of autoantibodies against brain proteins
and evidence of glia activation in mouse models do suggest an in-
volvement of the immune system in promoting the CNS pathology of
GWI (Abdullah et al., 2016; Abou-Donia et al., 2017; Joshi et al., 2018).
Increases in astroglia activation, nuclear factor kappa-B (NFκB)
phosphorylation and proinflammatory cytokines are commonly ob-
served in the brains of GWI rodent models (Abdullah et al., 2011, 2012,
2016; Parihar et al., 2013; Zakirova et al., 2015; Joshi et al., 2018).
Elevated proinflammatory cytokines can increase matrix
metalloproteinase 9 (MMP9) activity at the BBB and enhance the
transmigration process, potentially promoting the infiltration of per-
ipheral immune cells into the CNS (Song et al., 2015). Among these,
Ly6C+ monocytes are capable of converting to macrophages upon CNS
infiltration (Wohleb et al., 2013; Miró-Mur et al., 2016). Increases in C-
C chemokine receptor type 2 (CCR2) and its ligand, CCL2, were ob-
served in the brains of a GWI mouse model of combined PB and PER
(PB+PER) exposure (Joshi et al., 2018). In neuroinflammatory con-
ditions, CCL2 released by astroglia recruits CCR2-expressing peripheral
monocytes into the parenchyma, leading to the activation of NFκB-
mediated inflammatory pathways (Gerard and Rollins, 2001; Jimenez
et al., 2010; Bose and Cho, 2013; Harrison-Brown, Liu and Banati,
2016; Parillaud et al., 2017). These studies suggest that peripheral
adaptive immune responses could be involved in promoting neuroin-
flammation in GWI.
We hypothesize that exposure to PER results in 3-PBA-haptenation of
proteins and that haptenated proteins presented by antigen-presenting
cells (APC) could activate T- and B-cells, resulting in autoantibody pro-
duction. The presence of haptenated proteins in the CNS may promote
infiltration of peripheral immune cells, which would further contribute to
neuroinflammation. In this study, we determined the presence of 3-PBA
modified lysine (3-PBA-Lys) in proteins and 3-PBA recovered from pro-
tein hydrolysis in the brains and livers of a PB+PER GWI mouse model.
We examined the presence of autoantibodies against 3-PBA-haptenated
albumin in plasma from PB+PER exposed mice and in veterans with
GWI. We investigated the ability of 3-PBA-haptenated albumin to acti-
vate peripheral T- and B-cells and determined that these immune cells are
elevated in the blood of PB+PER exposed mice and in veterans with
GWI. We determined that proinflammatory monocytes capable of tissue
infiltration are present in the blood of PB+PER exposed mice. We also
examined infiltrating monocytes and macrophages derived from these
monocytes in the brains of PB+PER exposed mice. Collectively, these
studies will help determine the role of PER metabolites in activating
adaptive immune responses in GWI.
2. Material and methods
2.1. Human subjects
Plasma and/or peripheral blood mononuclear cells (PBMC) were
utilized from 3 different cohorts: (1) GWI and GW control veterans
recruited at the Roskamp Institute Clinics; (2) GWI cases and GW
controls from the Boston Gulf War Illness Consortium (GWIC); and (3)
subjects from Thailand who were farm workers or consumed pyre-
throid-infested fruits and vegetables and either had positive or negative
urine 3-PBA measurements. Plasma from age- and gender-matched GWI
and control GW veterans were used for this study. The Kansas GWI
criteria (Steele, 2000) were used to diagnose GWI. The Kansas GWI
criteria require that GW veterans show symptoms in at least 3 of 6
symptom domains (fatigue/sleep problems, somatic pain, neurological/
cognitive/mood symptoms, gastrointestinal symptoms, respiratory
symptoms, and skin abnormalities). Study participants were excluded if
they reported being diagnosed with another medical condition that
could explain their chronic health symptoms. Sample collection at the
Roskamp Institute Clinics was approved by the Western Institutional
Review Board (WIRB), and all protocols were conducted in accordance
with relevant guidelines and regulations. Recruitment of study subjects
and blood collection to obtain plasma and PBMC has been described
previously (Emmerich et al., 2017; Qiang et al., 2017; Joshi et al.,
2018) and demographic details are provided in Table 1A. Subjects were
also excluded from the study if they were currently on any steroid
medication to minimize interferences from the effects of these medi-
cations at the time of the blood draw. Controls were veterans deployed
to the 1991 GW who did not meet the Kansas GWI criteria or any of the
exclusionary criteria listed above. Plasma and PBMC collection at the
Boston GWIC were approved by the Boston University IRB. As described
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above, the Kansas GWI criteria (Steele, 2000) were used to diagnose
GWI, exclusion criteria are the same as those described for the cohort
above. Demographic details for GWIC samples are provided in Table 1B.
Self-report of pesticide exposure was based on questions which inquired
whether they had worn a uniform saturated with pesticide and/or used
pesticide cream/spray. Using these data, a summary variable was
generated which assigned yes/no to pesticide exposure. Since the ex-
posure status of GW veterans is based on self-report, we also examined
plasma from samples obtained from farm and non-farm workers with
documented exposure to pyrethroids and measurements of 3-PBA in
urine. These were occupational health worker who were exposed to
different pyrethroid pesticides during their occupation, and were used
as positive and negative controls for a 3-PBA-albumin autoantibody
detection assay. All the participants gave their written consents and the
study was approved by their respective IRBs. A detailed demographic
table is provided in Table 2. Many of these age- and gender-matched
people had been exposed to pyrethroids during their occupation, and
half of them had 3-PBA detected in their urine (n= 5 positive and
n=5 negative).
2.2. Animals
All procedures on mice were approved by the Roskamp Institute’s
Institutional Animal Care and Use Committee (IACUC) and were con-
ducted in compliance with the Office of Laboratory Animal Welfare and
laboratory animal care guidelines as previously described (Abdullah
et al., 2011; Zakirova et al., 2015). Mice were maintained with a 12 h
light/dark cycle in a temperature-controlled environment (21 ± 2 °C).
Male C57BL/6 mice (3months of age, weight 25 g ± 0.7 SD) were co-
administered 0.7 mg/kg of pyridostigmine bromide (PB) (Fisher Sci-
entific Hanover Park, IL) and 200mg/kg of PER (Sigma Aldrich, St.
Louis, MO, USA) in a single 50 μL intraperitoneal (i.p.) injection in
dimethyl sulfoxide (DMSO) (Sigma Aldrich, St. Louis, MO, USA) or
DMSO alone (control) daily for 10 consecutive days. Mice were divided
in two groups with the control group receiving vehicle only (DMSO)
and the GWI group receiving vehicle along with PB and PER. A timeline
of the study procedures is provided as Fig. 1.
2.3. Detection and quantification of 3-PBA using LC/MS reverse-phase
analysis:
Levels of 3-PBA in plasma, brain and liver were quantified as de-
scribed by Ahn et al. (2011). Briefly, 400mg of liver and 100mg of
brain from both control and PB+PER exposed mice were homogenized
in 1mL of PBS, and a protein crash was then performed via the addition
of 4mL of acetone. Samples were then subjected to acid hydrolysis by
Table 1A
Demographics of the Gulf War veteran autoantibody cohort.
Controls (GW
veteran)
GWI cases
N total 10 14
Age (Mean ± SEM) 54.3 ± 7.6 52.4 ± 7.5
Male (%) 79.7% 86%
Self-report of pesticide exposure during
war
5(50%) 95% (12)
Self-report of PB exposure during war 60% (6) 100% (14)
Ethnicity
Caucasian 8 (70%) 11 (78.4%)
African American 2 (3%) 2 (14.2%)
Other/Multiracial - 1 (7.13%)
There was no significant difference in age among two groups.
Table 1B
Demographics of the Gulf War veteran Boston consortium cohort.
Controls (GW veteran) GWI cases
N total 12 12
Age (Mean ± SEM) 51.23 ± 8.56 54.3 ± 7.4
Male (%) 83.33% 100%
Self-report of pesticide exposure during
war
25% (3) 83.33% (10)
Self-report of PB exposure 83.33% (10) 100% (12)
Ethnicity
Caucasian 9 (75%) 10 (83.4%)
African American 2 (16.67%) 1 (8.3%)
Other/Multiracial 1 (8.33%) 1 (8.3%)
There was no significant difference in age among two groups.
Table 2
Demographics of the subjects from Thailand.
Negative Controls (no urine
3PBA detected)
Positive cases (urine3-PBA
detected)
N total 5 5
Age (Mean ± SEM) 57.3 ± 7.6 61.4 ± 6.33
Male (%) 80% 80%
Pesticide exposure 20% (1) 66.6% (3)
PB exposure 0 0
Occupation
Farm worker 60% (3) 60% (3)
Non-farm worker 40% (2) 40% (2)
There was no significant difference in age among two groups.
Fig. 1. Timeline of study design.
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1mL 6M HCL at 100 °C for 2 h to hydrolyze covalent bonds between 3-
PBA and proteins (Ahn et al., 2011). These samples were subjected to
solid-phase extraction (SPE) using 8B-S100-UBJ Strata™-X 33 µm
polymeric reversed phase, 60mg/3mL spin columns (Phenomenex,
Torrance, CA, USA) for clean-up and spiked with 10 μM phenoxy-13C6-
3-PBA (Cambridge Isotope, Tewksbury, MA, USA) internal standard
(IS). Samples were analyzed by reverse-phase liquid-chromatography/
mass spectrometry (LC/MS) using a Shimadzu LC-20AT HPLC system
with a 2.6 µm EVO C18 100A 100×2.1mm Kinetex column (Phe-
nomenex, Torrance, CA, USA). The mobile phases used were as follows:
A (10mM ammonium formate in water); B (100% Acetonitrile (ACN)).
A gradient was run from 90% solvent A in 10% solvent B to 50% B in
6min with a 4min hold at 100% solvent B with a flow rate of 100 µL/
min and the column temperature was set at 40 °C. Mass spectrometry
analyses were conducted with high mass accuracy and parallel reaction
monitoring (PRM) using a Q-Exactive (QE) hybrid quadrupole-Orbitrap
mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA).
Negative ion electrospray spectra were acquired at 17,500 resolution
with a scan range from m/z 150 to 600. All spectra were obtained with
a 100ms maximum ion injection time and 5 microscans. The 3-PBA IS
(Cambridge Isotope Laboratories, Tewksbury, MA, USA) was monitored
with m/z 219.1 as the precursor mass and product ions at m/z 99.053
and 175.084. For 3-PBA, we used m/z 213.1 as the precursor ion and m/
z 93.033 and 169.065 as product ions.
2.4. Quantification of 3-PBA peptide using LC/MS reverse-phase analysis
Levels of 3-PBA bound lysine in plasma, brain and liver were
quantified as described by Noort et al. (2008). Briefly, 400mg of liver
and 100mg of brain from both control and PB+PER exposed mice
were homogenized in 1mL of PBS, and protein was precipitated by the
adding 4mL of acetone at −20 °C for 3 hrs. Precipitated protein was
digested with 100 µL of pronase solution (10mg/mL, 50mM
NH4HCO3) for 1 h at 37 °C followed by analysis with LC-tandem MS as
explained above. In-house synthesis of 3-PBA-albumin (described
below) was as standard. The 3-PBA-lysine was monitored with m/z
343.12 as the precursor mass and product ions at m/z 197.06.
2.5. Detection of 3-phenoxybenzoic acid in urine using GC-ECD
The first urine samples of the morning were collected and frozen at
−20 °C until they were analyzed for 3-PBA which was detected as de-
scribed by Pakvilai et al. (2014). Briefly, 50 µL of labeled 3-PBA (1 µg/
mL), as internal standard, was added to 2mL of urine sample, then
mixed for 30 s. The urine samples were subjected to acid hydrolysis by
adding 500 µL of concentrated hydrochloric acid (37%) at 100 °C for
2 h. Each sample was extracted twice with 2mL of ethyl acetate (EA),
followed by centrifugation at 2500 rpm for 5min. The organic phase
was separated, and sample cleanup was then performed on pre-condi-
tioned C18– cartridges. The resulting solution was dried and re-dis-
solved in acetonitrile. The 3-PBA was analyzed by using a Hewlett-
Packard 7890B-electron capture detector (GC-ECD) and Autosampler
G4513A (Agilent Technology, CA, USA) equipped with HP-5 (5%
phenylmethyl polysiloxane with 30m×0.25mm, 0.25 µm film thick-
ness) after derivatization by 1,1,1,3,3,3-Hexafluoroisopropanol (HFIP)
and N,N’-Diisopropylcarbodiim (DIC).
2.6. Preparation of 3-PBA-albumin conjugate
It has been shown that the 3-PBA metabolite of PER forms covalent
adducts with albumin, and, due to its high abundance, albumin is often
the major target of drug haptenation (Grigoryan et al., 2009; Tailor
et al., 2016). We chose albumin to test our hypothesis that 3-PBA can
also haptenate protein (3-PBA-albumin) and stimulate immune re-
sponses. We prepared a 3-PBA-albumin conjugate as described by Ahn
et al. (2007). Briefly, 65mg of 3-PBA (Sigma Aldrich, St. Louis, MO,
USA) and 92mg 1,3-dicyclohexylcarbodiimide (DCC) (Sigma Aldrich,
St. Louis, MO, USA) was dissolved in 4mL of N,N-Dimethylformamide
(DMF) (Sigma Aldrich, St. Louis, MO,USA). The active ester in 3-PBA
was formed by adding 52mg of N-hydroxysuccinimide (NHS) (Thermo
Fisher Scientific, Waltham, MA USA) and allowed to react for 5 hrs at
room temperature, after which 10mL of 50mM bovine or human serum
albumin in pH 8 borate buffer was added to the solution and allowed to
react overnight. The resulting precipitate containing 3-PBA-albumin
was collected and dialyzed (12,000 Da) against PBS for 3 days to re-
move low molecular weight contaminates. For mouse studies (including
blood culture studies), bovine albumin was used as previous studies
have shown that mouse and bovine serum albumin (BSA) share 72%
amino acid homology, and BSA is immunologically inactive in mice (Di
Domizio, Dorta-Estremera and Cao, 2013). For human studies, human
albumin was used.
2.7. 3-PBA-albumin autoantibody detection in the plasma
Both free albumin and 3-PBA-albumin were subjected to sodium
dodecyl sulfate (SDS) polyacrylamide gel electrophoresis in 4–20%
Criterion™ TGX Stain-Free™ Precast Gels (Bio-Rad, Hercules, CA, USA).
These proteins were then transferred to a polyvinylidene difluoride
(PVDF) membrane for 4 h at 60mA. After blocking in 5% milk for 1 h,
PB+PER mouse plasma and control mouse plasma were used as a
source of antibody. The membrane was incubated in PB+PER mice or
control mice plasma (1:300) overnight at 4 °C. Membranes were then
incubated in HRP-linked mouse secondary anit-IgG antibody, and the
blot was developed using SuperSignal West Femto Maximum Sensitivity
Substrate (Thermo Fisher Scientific Waltham, MA USA) and visualized
using a chemiluminescence imager (Bio-Rad, Hercules, CA, USA) as
described previously (Joshi et al., 2018). For human samples, the same
procedure was used with the exception that human secondary anti-IgG
was used.
2.8. Ex vivo whole blood flow cytometry studies
To test our hypothesis that 3-PBA albumin can stimulate immune
response and activate T- and B-lymphocytes, blood from 7-months old
control mice (C57BL/6) was collected following a cardiac puncture.
Blood was then combined with 2% EDTA and cultured in RPMI media
(Gibco, Carlsbad, CA, USA) at 37 °C in a humidified atmosphere con-
taining 5% CO2 supplemented with 1% of penicillin-streptomycin so-
lution and 10% FBS. Cultured blood was then treated with 5 µM 3-PBA-
albumin, 5 µM 3-PBA and 5 µM albumin for 12 h followed by red blood
cell (RBC) lysis and stained with antibodies against the cell surface
markers: CD4 (Thermo Fisher Scientific, Waltham, MA, USA), CD8
(Thermo Fisher Scientific, Waltham, MA USA), CD3 (Thermo Fisher
Scientific, Waltham, MA USA), CD19 (Thermo Fisher Scientific,
Waltham, MA USA), CD27 (Thermo Fisher Scientific, Waltham, MA
USA) and CD45R (B220) (Thermo Fisher Scientific, Waltham, MA,
USA). Detail on the antibodies used is provided in Supplementary Table
S4. These cells were analyzed using Attune® NxT Acoustic Focusing
Flow Cytometer (Thermo Fisher Scientific, Waltham, MA USA). Flow
cytometry analyses were done using Attune® NxT software version 2.7
(Thermo Fisher Scientific, Waltham, MA, USA). Flow cytometry data
were presented as total percentage change, and graphs were generated
using GraphPad Prism7. CD4+CD3+ staining was used to identify T-
helper cells while CD3+CD8+ staining was used to identify cytotoxic
T-cells (Alberts and Johnson, 2002). CD19+ and CD27+ were used to
distinguish memory and naïve B-cell population (Santer et al., 2013).
2.9. Detection of mouse blood monocytes and lymphocytes (B- and T-cells)
using flow cytometry
Whole blood was drawn from mice, and 100 µL was subjected to red
blood cell (RBC) lysis using 1mL of RBC lysis buffer (Thermo Fisher
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Scientific, Waltham, MA USA), washed twice with PBS-containing
5mM EDTA and 0.5% FBS and stained with CD45 (Thermo Fisher,
Waltham, MA USA), CD115 (BD bioscience, NJ, USA), Ly6C
(BioLegend, San Diego, USA) and CD11b (BD Bioscience NJ, USA) an-
tibodies for flow cytometry analysis. Details on the antibodies used are
provided in Supplementary Table S5. Monocytes were identified by
gating cells that were positive for both CD11b and CD115 (Randolph
et al., 2008; Greter et al., 2015). Patrolling and infiltrating monocyte
populations were identified by CD11b+ CD115+ with Ly6C- and
CD11b+ CD115+ with Ly6C+, respectively (Chao et al., 2013).
Ly6C+ monocytes are defined as proinflammatory and tissue-in-
filtrating while Ly6C++ are phagocytic monocytes (Randolph et al.,
2008). Flow cytometry analysis was conducted using combinations of
these monoclonal antibody using Attune® NxT Acoustic Focusing Flow
Cytometer (Thermo Fisher Scientific, Waltham, MA USA).
In another experiment, 150 μL of whole blood from the same mice
were lysed via addition of 1500 μL of RBC lysis buffer (Thermo Fisher
Scientific, Waltham, MA, USA). The monocytes and lymphocytes were
pelleted by centrifugation at 700×g for 10min and resuspended in
500 μL of FACS buffer (PBS, 0.5–1% BSA or 5–10% FBS, 0.1%), to
which 10 µL of CD4/CD8 antibody cocktail (Thermo Fisher Scientific,
Waltham, MA USA) was added. Cells were incubated with the cocktail
for 20min at room temperature. Lymphocyte populations were gated,
and CD4+ and CD8+ cells were analyzed using Attune® NxT Acoustic
Focusing Flow Cytometer (Thermo Fisher Scientific, Waltham, MA
USA). CD3+CD4+ are used to identify T-helper cells while
CD3+CD8+ cells are used to identify cytotoxic T-cells. These cells
were analyzed as described above. For B-lymphocytes, a combination of
CD27, CD19 and CD45R (B220) stains were used as described pre-
viously; detail on antibodies used is provided above. As described
previously, these were used to distinguish memory and naïve B-cell
population (Santer et al., 2013).
2.10. Labeling of human PBMC for T- and B-lymphocytes
The peripheral mononuclear cells provided by GWIC (Boston) were
treated with monoclonal antibodies conjugated to different fluor-
ophores. To find the T-cell population, cells were incubated with Anti-
human CD3/CD4/CD8 Cocktail (Biolegend, San Diego, CA USA). To
find the memory B-cell population, a combination of CD19 (Thermo
Fisher Scientific, Waltham, MA, USA) and CD27 (Thermo Fisher
Scientific, Waltham, MA, USA) antibodies were used and analyzed
using Attune® NxT Flow Cytometer as described above.
2.11. Flow cytometry studies of the brain myeloid and microglia cells
A single cell suspension was generated from adult mouse brains,
using the adult brain dissociation kit from Miltenyi Biotec (Cologne,
Germany) and closely following the manufacturer instructions. Briefly,
mouse brains were collected in serum-free media and chopped finely
with a sterile scalpel blade. The brains were subjected to a combination
of enzymatic Papain (1 μg/μL) mechanical digestion (pipetting up and
down 20 times) to yield a single cell suspension, the brain homogenate
was then passed through a 70 μm strainer, and the cell suspension was
centrifuged for 10min at 1000×g and 4 °C. Cell pellets were then re-
suspended in debris removal solution and carefully overlaid with 4mL
D-PBS as per manufacturer instructions; the samples were then cen-
trifuged at 3000×g for 10min at 4 °C in a swinging bucket rotor with
minimal brake. Following centrifugation, four phases were formed in
the tube, the upper 2 phases were aspirated, the remaining (glia cell
containing) fraction was then resuspended in PBS, inverted multiple
times and centrifuged at 1000× g for 10min to generate a pellet
containing a mixed glial cell population. The myeloid populations were
then isolated by magnetically activated cell sorting (MACS), using anti-
CD11b conjugated magnetic microbeads (Miltenyi Biotec, Cologne,
Germany) according to the manufacturer's protocol. Briefly, cells were
incubated with 10 μL CD11b coated microbeads for 15min at 4 °C. Cells
were then washed and placed on a new LS magnetic column (Miltenyi
Biotec, Cologne, Germany) in a magnetic holder. The CD11b negative
fraction was washed through the column, and the CD11b positive cell
fraction was eluted from the column by removing the column from the
magnetic field, adding buffer and emptying the column with a plunger.
Cells were incubated with Rat anti-mouse Fc-block (1:100 BD
bioscience) for 5min at room temperature. These cells were then
stained with monoclonal antibodies for desired surface markers. The
antibodies used were CD11b (BioLegend San Diego, USA), CX3CR1
(BioLegend, San Diego, USA), Ly6c (BioLegend San Diego, USA) and
CD206 (BioLegend San Diego, USA). Details on the antibodies used are
provided in the Supplementary Table S6. These cells were analyzed as
described above using an Attune® NxT Acoustic Focusing Flow Cyt-
ometer (Thermo Fisher Scientific, Waltham, MA USA). A combination
of CD11b+, CX3CR1+, CD206+, and Ly6C+ staining was used to
analyze brain macrophages, and cells stained with CD11b+,
CX3CR1+, and CD206− were classified as microglia (Han et al., 2015;
Wong et al., 2017; Zhou et al., 2017; Zarruk et al., 2018).
2.12. Immunostaining for microglia and astrocytes
The left-brain hemispheres were fixed in 4% paraformaldehyde
(PFA), dehydrated and embedded in paraffin. Sagittal sections (8 μm)
were prepared using Leica RM2235 microtome (Leica, Buffalo grove,
IL). Approximately 8 to 10 slices of each mouse brain were incubated in
blocking buffer (10% donkey serum and 0.3% Triton X-100 in PBS) for
60min at room temperature. Samples were then incubated overnight
with the primary antibody Rabbit anti-IBA-1 (Wako, Osaka, Japan) and
Chicken anti-GFAP (Aves Lab, Tigard, Oregon) at 4 °C. The following
day, slices were incubated with the appropriate fluorescent probe-
conjugated secondary antibodies for 1 hr at room temperature. Nuclei
were counterstained with DAPI. The entire DG was scanned using an
Axiovert 200M Zeiss microscope (Zeiss) equipped with AxioVision
4.8.3.0 software. ImageJ software was used to analyze the stained sa-
gittal sections. The stained areas were calculated and expressed as a
percentage of the field. Further detail on primary and secondary anti-
bodies used for brain pathology is provided in Supplementary Table S7.
2.13. Enzyme-linked immunosorbent assay
Using a Dounce homogenizer, brains were homogenized in ice cold
Mammalian Protein Extraction (mPER) buffer (Thermo Fisher
Scientific, Waltham, MA USA), which contained protease (Roche,
Indianapolis, IN, USA) and phosphatase inhibitor (Pierce, Grand Island,
NY, USA) cocktails. These whole brain homogenates were centrifuge at
10,000×g for 10min, and supernatant was used for ELISA and Western
blot. The total protein content of each sample was determined by the
bicinchoninic acid (BCA) assay (Pierce, Grand Island, NY, USA).
Enzyme-Linked Immunosorbent Assay (ELISA) kits for mouse CCR2
(Lifspan Biosciences, Seattle, WA,USA), CCL2 (Lifspan Biosciences,
Seattle, WA, USA), Matrix Metalloproteinase-9 (MMP9) (Bosterbio,
Pleasanton, CA, USA) and fractalkine (CX3CL1) protein (MyBiosource,
San Diego, CA,USA) were used to study levels of these proteins in the
brain using the manufacturer’s protocol. Soluble CX3CL1 (Thermo
Fisher Scientific, Waltham, MA USA) in human plasma were quantified
using a commercial ELISA kit. The level of IgG protein in blood was
quantified by IgG ELISA (Cayman Chemical, Ann Arbor, MI, USA) ac-
cording to the manufacturer’s instruction. MMP9 is a proteolytic pro-
tein capable of degrading tight junction protein leading to BBB im-
pairment (Underly et al., 2016; Schactae et al., 2017). Results were
normalized to total protein quantification obtained from BCA. Intra-
Assay: CV < 10.6% Inter-Assay: CV < 12.6% for all the ELISAs. There
was no reported cross-reactivity with other proteins for the primary
antibody used in these kits.
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2.14. Western blot analyses
CX3CR1 (Abcam, Cambridge, MA, USA), p-65(p-NFκB) phosphory-
lated at Ser536 (Cell Signaling, Danvers, MA, USA), total p65 (NFκB)
(Cell Signaling, Danvers, MA, USA), tubulin (Abcam, Cambridge, MA,
USA), major histocompatibility complex-II (MHC-II) (Abcam
Cambridge, MA, USA), actin (Cell signaling, Danvers, MA, USA) and
occludin (Santa Cruz biotechnology, Santa Cruz, CA, USA) were ana-
lyzed using Western Blotting. MHC-II are markers of antigen-presenting
cells (Lehnardt et al., 2003; Vaure and Liu, 2014). In the brain, mi-
croglia and macrophages are the main cells expressing MHC-II
(Lehnardt et al., 2003). Occludin is a tight junction protein used to
analyzed BBB impairment (Liebner et al., 2000; Yang et al., 2017).
Western Blotting was performed as described previously (Joshi et al.,
2018). A list of primary antibodies used is provided in the
Supplementary Table S8 along with the dilutions and sources. Horse-
radish peroxidase-conjugated appropriate secondary antibodies and
loading control anti–β-actin or tubulin antibody was obtained from Cell
Signaling. The blots were analyzed as described previously (Joshi et al.,
2018). Briefly after the BCA (as described above), 20 μg of protein from
whole brain homogenate were heated with Laemmli buffer containing
beta-mercaptoethanol (BioRad, Hercules, CA, USA) and separated by
gel electrophoresis using 4–15% Criterion™ TGX Stain-Free™ Protein
Gel, (Biorad, Hercules, CA, #5678085) and then transferred to a PVDF
membrane (Biorad, Hercules, CA) overnight at 90mA. The membranes
were blocked for 1 h in 5% blocking milk (BioRad, Hercules, CA, USA).
Then, each membrane was individually immunoprobed with a primary
antibody in blocking buffer overnight. After each primary antibody
incubation, each membrane was incubated with the recommended di-
lution (1:5000) of corresponding horseradish peroxidase-conjugated
secondary antibody (cell signaling) in blocking buffer at room tem-
perature for one hour. Protein bands were visualized using enhanced
chemiluminescence detection reagents (Thermo Scientific, MA USA).
Band intensities were analyzed using the ChemiDoc imaging system
(Bio-Rad). Results were calculated using Image Lab software and nor-
malized to the expression of actin protein in the samples.
2.15. Multiplex cytokine assay
Selected cytokine levels in the plasma were analyzed using Meso
Scale Discovery (MSD) 96-Well MULTI-SPOT® Ultra-Sensitive V-PLEX
Proinflammatory cytokine Panel 1 mouse Kit (MSD, Rockville, MD,
Fig. 2. Metabolites of PER pesticide is detected as protein adducts in the brain and liver homogenates. (A) A schematic of PER metabolites. (B) Detection of precursor
and product ion of 3-PBA lysine (343.2) and its product ions (197.06) in the brain and liver homogenates from a GWI mouse sample. (C and D) Using LC-MS and LC-
MS/MS, we detected 3-PBA (m/z 213.055 at 3min) and its PRM product ion (m/z 213.1 > 93.033 at that same time) in the brain and liver (mean ± SE (n=4 or 5/
group). While only protein-conjugated 3-PBA recovered after hydrolysis was detected in the brain, free 3-PBA and protein-conjugated 3-PBA were detected in the
liver at 1.5months post-exposure. (E and F) Peak plots show absence of 3-PBA (m/z 213.055 at 3 min) and its transition ion (m/z 93.033) ions in control mice. These
peak plots show presence of 3-PBA internal standard 219.1 at 3 min and its transition ion (m/z 93.033) ions in control mice.
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USA), using electrochemiluminescence detection on an MSD Sector
Imager™ 6000 with Discovery Workbench software (version 3.0.18)
(MSD®, Gaithersburg, MD, USA). Cytokines were measured using the
TH1/TH2 8-plex kit which included interleukin-1β (IL-1β), IL-6, in-
terferon-γ (IFN-γ) and tumor necrosis factor-α (TNFα). All assays were
performed according to the manufacturer’s instructions, in duplicates as
described previously (Joshi et al., 2018). Human plasma was analyzed
using V-PLEX Proinflammatory cytokine Panel 1 Human Kit (MSD,
Rockville, MD, USA) according to manufacturer protocol.
2.16. Statistical analyses
Normally distributed data were analyzed using parametric tests;
otherwise non-parametric tests were used. As applicable, the Student’s
t-test was used to examine the group differences between PB+PER
mice and control mice for cytokines, chemokines, percentage of specific
cells identified using flow cytometry and protein levels of p-NFκB, oc-
cludin, MMP9, IgG and MHC-II. Murine cytokine data were analyzed by
using the Student’s t-test. Human cytokine data were not normally
distributed, so the Kolmogorov-Smirnov test (K-S test) was performed
on them to check if they were statistically significant. For autoantibody
analysis in the GW veteran cohort, the Chi-square test was performed to
determine statistical significance. For multiple groups in blood culture
studies, we used one-way analysis of variance (ANOVA) followed by the
Tukey post-hoc test. A p value < 0.05 was considered statistically sig-
nificant. These analyses were performed using GraphPad Prism7 (San
Diego, CA, USA), and data were expressed as means ± standard errors.
All graphs were generated using GraphPad Prism7 (San Diego, CA,
USA).
3. Results
3.1. Detection of 3-PBA released following protein hydrolysis and 3-PBA-
modified lysine residues from peptides in the brain, liver and plasma of
PB+ PER mice
For an acute post-exposure timepoint, we examined 3-PBA modified
proteins in liver, brain and plasma of PB+PER exposed mice eu-
thanized at 1-day post-exposure. We also examined a serum sample of a
subject positive for 3-PBA in urine as a positive control. Fig. 2 shows
PER metabolite structures and detected ions that correspond with the
presence of 3-PBA lysine residues after pronase digestion that was
performed to release these adducts from peptides (Fig. 2B). We also
quantified 3-PBA released post-protein-hydrolysis which showed the
presence of 3-PBA in the livers and brains of PB+PER mice at
1.5 months post-exposure (Fig. 2C and 2D). However, free 3-PBA was
detected only in the livers but not in the brains of exposed mice. As
expected, no 3-PBA was detected in control mice (Fig. 2E and 2F).
Neither free nor protein-conjugated 3-PBA was detected in the brains or
livers of exposed mice at 3- or 7-months post-exposure.
3.2. 3-PBA-albumin autoantibodies in plasma from PB+PER mice and in
GWI veterans.
Western blot analyses showed that while plasma from control mice
did not have immunoreactivity to free albumin or 3-PBA-albumin,
plasma from PB+PER exposed mice showed a strong im-
munoreactivity with 3-PBA-albumin but not with free albumin
(Fig. 3A). We then examined if 3-PBA human albumin-reactive auto-
antibodies were detectable in plasma from GW veterans. Plasma from
10 out of 12 GW veterans diagnosed with GWI showed im-
munoreactivity to 3-PBA-albumin, and 1 out of 10 healthy GW veterans
had immunoreactivity to 3-PBA albumin (χ2=11.73, df= 1,
p=0.001, Fig. 3B). Details of these antibodies detected is provided in
table 1A. None of the plasma samples from GW veterans showed any
immunoreactivity to albumin alone (Fig. 3B). There was a significant
association between self-report of pesticide exposure and 3-PBA-al-
bumin autoantibody presence among veterans with GWI (χ2=9.46,
df= 1, p=0.03). Only one control GW veteran had 3-PBA-albumin
autoantibodies and was exposed to pesticides. Additionally, this control
GW veteran reported being exposed to PER but not to PB and auto-
antibodies against 3-PBA-albumin were still detected in plasma. Also,
no 3-PBA-albumin autoantibodies were detected in plasma from one
GWI case who was exposed to PB but not PER. Two additional controls
who didn’t have autoantibodies did report pesticide exposure, where
one subject had an exposure to fogged area whereas the other subject
did report exposure to pesticide imbedded uniforms, creams and sprays.
In another cohort from Thailand, we detected 3-PBA-albumin auto-
antibodies in the serum of 5 subjects who had positive 3-PBA urine
levels, whereas 5 control serum samples with undetectable urinary 3-
PBA levels did not show immunoreactivity to 3-PBA-albumin (Fig. 3C).
Both human and mice secondary antibody alone showed no cross re-
activity with albumin or 3-PBA-hapten (Supplementary Fig. S7).
3.3. Peripheral T-cells and B-cells activated following 3-PBA-albumin
treatment
Murine blood was cultured overnight to examine if 3-PBA-albumin
as compared to albumin alone, 3-PBA alone and control treatments can
activate B-cells, T-cells and monocytes. Antigen-responsive CD19+
CD27+ B-cells were significantly different between the four groups
(F(3,12)= 12.2, p=0.001, Fig. 4A), with the 3-PBA-albumin group
being significantly elevated compared to all other groups (post-hoc
p < 0.05). Consistently, IgG levels were increased by 3-PBA-albumin
treatment compared to all other groups (F(3,12)= 221.8, p=0.001
Supplementary Fig. S1A). Group comparisons for CD3+ CD4+ T-
helper cells showed significant differences between treatments
(F(3,16)= 61.19, p=0.001, Fig. 4B) with post-hoc analyses showing
increases in CD3+CD4+ T-helper cells by 3-PBA-albumin treatment as
compared to controls, 3-PBA and albumin alone (p < 0.05). There
were no differences in CD3+CD8+ T-lymphocytes when treated with
3-PBA-albumin compared to all other treatments (p > 0.05). Total
monocyte population gated by CD11b+ and CD115+ differed sig-
nificantly between the groups (F(3,12)= 20.48, p=0.001,
Supplementary Fig. S1B), and post-hoc comparisons showed an increase
in these cells in the 3-PBA-albumin group compared to others
(p < 0.05).
3.4. Activated peripheral immune cells and plasma proinflammatory
cytokines are increased in the blood of PB+PER mice and veterans with
GWI
An antigen-reactive B-cell population positive for CD45+CD19+
CD27+ was elevated in the blood of PB+PER mice compared to
control mice (t-test(df=6)= 5.7, p=0.0012, Fig. 5A). However, the
CD19+CD27− population did not differ between the two groups
(p > 0.05), suggesting that while total B-cell population doesn’t
change, antigen-responsive B-cells proportionally increase. Higher le-
vels of IgG were present in blood from PB+PER exposed compared to
control mice (t-test(df=5)= 4.5, p=0.008, Supplementary Fig. 1C). We
analyzed CD4+ and CD8+ markers after gating on the blood lym-
phocyte population. This study revealed that CD4+ T-helper cell po-
pulation was significantly higher in the lymphocytes of exposed com-
pared to control mice (t-test(df=7)= 2.7, p=0.024, Fig. 5B). T-helper
cells expressing CD3+CD4+ were also elevated in the blood of
PB+PER exposed mice (t-test(df=6)= 5.3, p=0.0017, Fig. 5B). Al-
though CD8+ lymphocytes didn’t differ between the two groups
(p > 0.05), the ratios of CD4+ to CD8+ cells were elevated in
PB+PER exposed compared to control mice (t-test(df=6)= 3.7,
p=0.0014, Fig. 5B). Mouse monocytes defined by CD11b+ and
CD115+ cells were elevated in PB+PER exposed compared to control
mice (t-test(df=11)= 4.2, p=0.0012, Supplementary Fig. S2). In
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addition, at 7months post-exposure, several proinflammatory cyto-
kines, including IL-1β, IL-6, IFN-γ and TNF-α and a chemokine CX3CL1
were elevated in the brain and plasma from this PB+PER mouse
model (Supplementary Fig. S3).
We also examined peripheral T- and B-cells in PBMCs from GWI and
control GW veterans. The memory B-cell population, as defined by
CD19+CD27+ cells, was significantly increased in GWI compared to
healthy GW veterans (t-test(df=20)= 5.01, p=0.0014, Fig. 6A). T-
helper cells expressing CD3+CD4+ are also elevated in GWI veterans
(t-test(df=28)= 8, p=0.001, Fig. 6B). Although CD3+ CD8+ T-cells
didn’t differ between the two groups (p > 0.05), the ratios of CD4+ to
CD8+ cells were elevated in GWI compared to control GW veterans (t-
test(df=20)= 3.7, p=0.0014). Compared to healthy GW veterans,
plasma levels of proinflammatory cytokine IL-1β and CX3CL1 were
higher in veterans with GWI (Supplementary Fig. S4).
3.5. Disruption of the BBB in PB+PER mice
Since MMP9 is increased during inflammation, we examined MMP9
levels in the brain homogenates from PB+PER mice and control mice.
MMP9 was significantly higher in the brains of PB+PER exposed mice
(t-test(df=9)= 2.7, p=0.028, Fig. 7B). Assessment of BBB integrity
examined using occludin showed a significant decrease in PB+PER
exposed mice compared to control mice (t-test (df= 10)= 2.5, p=0.029,
Fig. 7A). Increases in brain IgG levels are generally indicative of BBB
impairment, and levels of IgG were increased in the brains of PB+PER
exposed mice compared to controls (t-test (df= 9)= 3.71, p=0.043,
Fig. 7B).
Fig. 3. Chronic elevation of autoantibodies against
3-PBA-albumin in plasma of PB+PER mice, in
veterans with GWI and in farm workers exposed to
pyrethroids. Western Blot showed that control mice
had no cross-reactivity to 3-PBA-albumin or al-
bumin alone, but cross-reactivity in PB+PER mice
plasma was observed for 3-PBA-albumin at 1.5-, 3-
and 7-months post-exposure in PB+PER mice
(n=4 or 5/group). (B) Autoantibodies against 3-
PBA-albumin were detected in 12 out of 14 ve-
terans with GWI and 1 out of 10 control GW ve-
terans. (C) Immunoreactivity of plasma with 3-
PBA-albumin was observed in 5 out of 5 pyrethroid-
exposed farm workers or ate pyrethroid tainted
fruits and vegetables (as confirmed using 3-PBA
measurements in urine), and a lack of im-
munoreactivity in controls in whom urine 3-PBA
was undetected.
Fig. 4. 3-PBA-albumin treatment increased memory B-cell and T-helper cells in 7months old control mice. Mean ± SE (n=4 per group). (A) After overnight
incubation of murine blood with 3-PBA, albumin and 3-PBA-albumin, antigen-responsive CD45+ CD19+ CD27+ B-cells are significantly elevated in 3-PBA-albumin
compared to all other treatments. (B) T-helper cells, CD3+CD4+, were also elevated upon 3-PBA-albumin treatment. Comparisons between 3-PBA and controls and
albumin and controls were not significant. *p < 0.05.
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Fig. 5. Antigen-activated B- and T-cells are increased in blood of PB+PER mice at 7months post-exposure. Mean ± SE (n=4/5 per group). (A) Increased staining
of antigen-responsive CD19+ CD27+ B-cells were detected in GWI compared to control mice. (B) Panel B shows that CD3+CD4+ T-cells are increased in blood of
PB+PER mice. However, CD8+ T-cells did not differ between the two groups. Ratios of CD4:CD8 was significantly elevated in PB+PER mice. *p < 0.05.
Fig. 6. Memory B- and CD4 T-cells are increased in blood of veterans with GWI. Mean ± SE (n= 12 per group). (A) Increased staining CD19+ and CD19+ CD27+
memory B-cells in blood of veterans with GWI compared to healthy GW control veterans. (B) CD3+ CD4+ TH cells are increased in blood of veterans with GWI.
However, CD8+ TH cells did not significantly differ between control and GWI veterans. However, there were no group differences for CD3+CD8+ TH cells.
*p < 0.05.
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3.6. Infiltrating monocyte population in the blood and brain of PB+ PER
mice
Monocytes staining with CD11b+ CD115+ and Ly6C+ classified
as proinflammatory and infiltrating were elevated in PB+PER exposed
mice blood compared to control mice (t-test(df=11)= 3.7, p=0.0032,
Fig. 8A). Macrophages were detected using CD11b+ CD206+ Ly6C+
positive stains, which were increased in the brains of PB+PER exposed
mice compared to control mice (t-test(df=2.8)= 4.7, p=0.04, Fig. 8B).
The microglia population characterized by CD11b+, CX3CR1+,
CD206− Ly6C− showed no differences between the two groups
(Fig. 8C). Infiltrating monocytes detected by CD11b+ CX3CR1−
Ly6C+ were significantly increased in the brains of exposed mice
compared to controls (t-test(df=4)= 4.7, p=0.01, Fig. 8D). Patrolling
monocyte populations (CD11b+ CX3CR1+) were significantly in-
creased in the brain of PB+PER exposed mice (t-test(df=6)= 6.2,
p=0.032, Supplementary Fig. 2B). We also observed increased MHC-II
protein levels in the brains of PB+PER exposed mice compared to
controls (t-test(df=6)= 6.2, p=0.0007, Fig. 8E).
3.7. Chemokines and their receptors that promote CNS and peripheral
immune cross-talk are increased in PB+PER mice
Since plasma CX3CL1 levels were increased in PB+PER exposed
mice and in veterans with GWI (Supplementary Figs. 3 and 4), we ex-
amined its receptor CX3CR1 in the brain homogenates from PB+PER
mice and control mice at 7-months post-exposure. Levels of CX3CR1
were elevated in PB+PER mice compared to control mice (t-
test(df=5)= 3.1, p=0.03, Fig. 9A). There were no differences in the
membrane fraction of the brain homogenates for CX3CL1 levels be-
tween PB+PER exposed mice and control mice at 7-months post-ex-
posure (p=0.86, Fig. 9B). Levels of CCR2 (t-test(df=10)= 4.71,
Fig. 6. (continued)
Fig. 7. PB+PER mice showed evidence of BBB impairment. Mean ± SE (n= 6 per group). (A) Occludin was decreased in the brains of PB+PER mice whereas (B)
MMP-9 and IgG were increased in PB+PER mice brain. (C) Representative images of MMP-9 western blot of whole brain homogenate. Band intensities from control
and PB+PER animal brain tissue (n=4). *p < 0.05.
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Fig. 8. Infiltrating monocytes are increased in blood and brains of PB+PER mice at 7–8months post-exposure. Mean ± SE (n= 12 per group) (A) Increases in
blood monocyte gated by CD11B+ CD115+ and Ly6C+ in PB+PER mice were observed. (B) PB+PER mice brain showed increased macrophage population as
detected by CD11b+CD 206+Ly6C+ but (C) no change in microglia population detected by CD11b+CX3CR1+ and CD206−. (D) Infiltrating monocytes con-
verting to macrophage (CD11b+, CX3CR1− and Ly6C+) were also increased in the brains of PB+PER mice. (E) Increase in MHC-II in the brain of PB+PER mice
was detected by Western Blot *p < 0.05.
Fig. 9. CCR2 and its ligand CCL2 are chronically increased in the brains of PB+PER-exposed mice leading to inflammation. Mean as % control ± SEM (n=6 per
group). (A) Western Blot showing CX3CR1/actin and pNFκB/NFκB is increased in the brains of PB+PER-exposed mice. (B) No change in CX3CL1 level as measured
by ELISA. (C) Levels of CCL2 were also increased in PB+PER-exposed mice at 7-months post-exposure. (D) CCR2 levels were increased in the brains of PB+PER
mice. *p < 0.05.
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p=0.0008, Fig. 9C) and its ligand CCL2 (t-test(df=10)= 3.9, p=0.003,
Fig. 9D) were increased in the brains of PB+PER exposed mice com-
pared to control mice. Immunohistochemistry work showed astroglia
activation in the dentate gyrus and cortex of PB+PER mice compared
to control mice (Supplementary Fig. S5). We examined the ratios of
phosphorylated p65 (p-NFκB) to total p65 (NFκB) in PB+PER exposed
mice to assess inflammation. There was a significant increase in p-
NFκB/NFκB ratios (t-test(df=5)= 2.2, p=0.06, Fig. 8A). Post-hoc ana-
lyses showed that the ratios of p-NFκB/NFκB were increased in
PB+PER mice at this 7-months post-exposure timepoint.
4. Discussion
Evidence suggests that overexposure to PB and pesticides, which
included pyrethroids and organophosphates, was one of the etiological
factors in GWI (Binns et al., 2008; White et al., 2016; Sullivan et al.,
2018). Exposure to these compounds has been shown to induce chronic
immune dysfunction (Broderick et al., 2013; Craddock et al., 2015;
Jokanović, 2018). While clinical symptoms of GWI resemble those of
autoimmune diseases, the exact mechanism by which GW chemicals
caused immune activation remains unknown. In this translational
study, we show that a common pyrethroid metabolite, 3-PBA, can
haptenate albumin, which activates CD4+ T-helper and antigen-re-
sponsive B-cells. These immune cells were elevated in PB+PER ex-
posed mice and in veterans with GWI. We observed autoantibodies
against 3-PBA-albumin in our PB+PER mouse model and in veterans
with GWI at chronic post-exposure timepoints. In this PB+PER mouse
model, we also show that brain macrophages thought to be derived
from peripheral blood monocytes were increased in the brains of
PB+PER exposed mice. These studies suggest that activation of au-
toimmune responses against endogenous proteins modified by 3-PBA
corresponds with activation of brain macrophages and neuroin-
flammation in PB+PER exposed mice. The work described herein
could aid in the development of sensitive and specific biomarkers for
diagnosing GWI in order to provide appropriate care and treatment to
veterans with GWI.
During the 1991 GW, a large proportion of veterans were using
pyrethroid-based pesticides routinely (Binns et al., 2008; Sullivan et al.,
2018). To date, accurate diagnosis of GWI remains an unmet need for ill
GW veterans. One reason it is difficult to accurately diagnose GWI is
because the diagnosis is based on self-report of symptoms and ex-
posures. Since studies have shown that 3-PBA can form adducts with
lysine residues on endogenous proteins (Noort, Benschop and Black,
2002; Noort et al., 2008; Thiphom et al., 2012), we performed this
experiment and found a presence of 3-PBA-lysine residues in the brain,
blood and liver of PB+PER exposed mice acutely after GW chemical
exposure. We also examined 3-PBA recovered after protein hydrolysis
and found it to be present at 1.5 months after exposure to PB and PER
but not at later post-exposure timepoints. This suggests that 3-PBA-
haptenated proteins are eventually eliminated. Small molecules which
haptenate endogenous proteins can elicit adaptive immune responses,
ultimately resulting in B-cell activation and autoantibody production
(Naisbitt et al., 2002; Palm and Medzhitov, 2009). Since albumin is
easily haptenated by drugs due to its abundance in blood and avail-
ability of lysine residues that can be covalently modified (Tailor et al.,
2016), albumin was chosen for haptenation studies with 3-PBA. Our
observations of autoantibodies against 3-PBA-albumin in blood from
PB+PER exposed mice, veterans with GWI and pyrethroid-exposed
subjects suggest that 3-PBA-albumin is capable of provoking auto-
immune responses. These studies for the first time provide evidence of
autoantibodies following pyrethroid exposure in veterans with GWI.
The specificity of these autoantibodies to pyrethroid exposure is further
supported by the observation of 3-PBA-albumin autoantibodies in
subjects with detectable urinary 3-PBA levels and observable 3-PBA-
lysine adducts in their serum. While it remains to be determined if
autoantibodies against 3-PBA-albumin have a pathological role in GWI,
a higher prevalence of these autoantibodies in GWI veterans compared
to control GW veterans suggests that they could be useful biomarkers of
GWI.
Our animal and human studies suggest that autoantibodies against
3-PBA-albumin persist for a long time, despite the fact that 3-PBA is not
detected in the brain or the liver beyond 1.5 months post-exposure.
Studies have shown that proteins haptenated by other chemicals can
directly interact with APC, which then travel to the lymphatic system
where they present these antigens to T- and B-cells (Karlsson et al.,
2018). This may result in the production of autoantibodies against
haptenated proteins (Lanzavecchia, 1985; Gefen et al., 2015; Karlsson
et al., 2018). While the exact mechanism behind the persistence of
autoantibodies against 3-PBA-albumin remains to be investigated, it
may involve a similar mechanism which requires memory B-cell acti-
vation and subsequent autoantibody production by plasma B-cells
(Ochsenbein et al., 2000; Alberts and Johnson, 2002). As mentioned
above, we show that autoantibodies against 3-PBA-albumin are gener-
ated in our PB+PER mouse model. Furthermore, results of our in vitro
blood culture studies suggest that the adaptive immune system is en-
gaged in promoting immune cell activation after 3-PBA-albumin
treatment, which is characterized by an elevation of antigen-presenting
monocytes, CD3+CD4+ T-helper cells and antigen-responsive CD19+
CD27+ B-cells. Interestingly, these cells did not react to 3-PBA or al-
bumin alone, further strengthening the concept that chemical hapte-
nation of albumin is required to elicit adaptive immune responses and
that 3-PBA alone cannot promote immune activation. Increases of
CD3+CD4+ T-helper and CD19+ CD27+ B-cells, together with the
presence of autoantibodies against 3-PBA-albumin in PB+PER mice
and in GWI veterans, further support an autoimmune-type response in
GWI. These studies provide support for an activation of the adaptive
immune system in GWI and are consistent with those conducted by
Vojdani and Thrasher (2004), showing an elevation of CD4+ T-helper
cells and B-cells in the blood of veterans with GWI. Together, these
findings suggest that 3-PBA-albumin can stimulate peripheral immune
cell activation.
While most veterans deployed in the GW conflict self-report the use
of PB, it is unlikely that PB alone is a major contributing factor in the
overactive immune responses noted in veterans with GWI. On the
contrary, previous research has suggested that PB is able to suppress
inflammation in rodent models (Macht et al., 2019), with exposure to
PB alone resulting in decreased production of pro-inflammatory cyto-
kines such as IL-6, IFN-y and TNF-α at chronic time points (Macht et al.,
2018). However, we, along with others, have shown that these cyto-
kines are elevated in plasma from veterans with GWI (Broderick et al.,
2011; Khaiboullina et al., 2015). The mechanism of PB is well defined
in the literature, acting as a reversible acetylcholinesterase (AchE) in-
hibitor (Musilek et al., 2011). As such, PB use would likely result in an
increase in acetylcholine (ACh) levels in the periphery (Musilek et al.,
2011). Recent evidence suggests a role of ACh in stimulating anti-in-
flammatory responses in the periphery via a direct interaction with
nicotinic receptors on peripheral immune cells (Tracey, 2005; Ibrahim
et al., 2018). Therefore, one would expect a dampened immune re-
sponse in PB+PER exposed mice. However, since we observe activated
immune responses and the presence of 3-PBA-albumin autoantibodies
in plasma of both human and PB+PER exposed mice, it is possible that
PB was unable to suppress immune cell activation that occurs in the
presence of combined PB+PER exposure (Joshi et al., 2018). Addi-
tional research is needed to clarify if PB metabolites may also form
haptenated proteins, which may promote synergistic interactions re-
sulting in the observed adverse adaptive immune response.
Under normal physiological conditions, the BBB largely restricts
entry of peripheral immune cells into the brain, which helps maintain
the immune privilege status of the CNS (Van Dyken and Lacoste, 2018).
However, peripheral immune cells have been shown to migrate into the
brain parenchyma during inflammation resulting from the increases in
proinflammatory cytokines and MMP9 activity which weakens the BBB
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(Yabluchanskiy et al., 2013; Song et al., 2015; Van Dyken and Lacoste,
2018). We observed elevated proinflammatory cytokines, such as IL-1β
and/or TNF-α, in the brains and blood of PB+PER mice (Joshi et al.,
2018). Similarly, other studies also support an elevation of proin-
flammatory cytokines in rodent models of GWI as well as in plasma
from veterans with GWI (Khaiboullina et al., 2015; Parkitny et al.,
2015; Shetty et al., 2017; Joshi et al., 2018). As such, our observations
of increases in these proinflammatory cytokines and in MMP9 and a loss
of occludin in PB+PER exposed mice suggests BBB disruptions. Stu-
dies on other autoimmune disorders show that autoantibodies against
peripheral antigens can enter the brain when the BBB is compromised.
Upon entering the brain, they may cross-react with brain proteins, as in
the case of SLE where peripherally generated anti-DNA autoantibodies
can cross-react with NMDA receptors (Diamond et al., 2009; Brimberg
et al., 2015). Hence, a similar mechanism could explain the CNS pa-
thology of GWI, but this requires further investigation.
We also detected 3-PBA-lysine and 3-PBA recovered after protein
hydrolysis in the brain. Hence, it is possible that a presence of 3-PBA-
protein adducts in the brain could elicit an immune response. While the
exact mechanism of how 3-PBA-proteins in the brains of PB+PER mice
initiate an immune response is unknown, persistent activation of as-
troglia suggests that these cells are involved in modulating CNS im-
mune responses following 3-PBA-protein adduct formation.
Alternatively, astroglia activation may be secondary to BBB damage as
observed in this and other GWI rodent models (Abdel-Rahman et al.,
2004; O’Callaghan et al., 2015; Abdullah et al., 2016; Joshi et al.,
2018).
Evidence of adaptive immune responses in GWI comes from our
observations of increased CCL2 chemokines in the brains of PB+PER
exposed mice, which is also reported in other models of GWI (Locker
et al., 2017; Shetty et al., 2017). In other autoimmune conditions and in
a pesticide-induced mouse model of Parkinson’s disease, release of
CCL2 by astroglia is shown to promote an ingress of bone-marrow-de-
rived CCR2-expressing monocytes into the brain parenchymal space
(Rothhammer and Quintana, 2015; Harrison-Brown et al., 2016;
Parillaud et al., 2017). In addition, CX3CR1 is also expressed on bone-
marrow derived monocytes whose levels are inversely proportional to
both Ly6C and CCR2 in the blood (Jacquelin et al., 2013). We also
observed increases in CX3CR1 in the brain homogenates of PB+PER
exposed mice. Ligation of this receptor by its ligand CX3CL1 promotes
monocyte migration survival and promotes chronic inflammation
(O’Sullivan et al., 2016; Parillaud et al., 2017). It is now well-docu-
mented that peripheral monocytes are a source of brain macrophages
that are distinct from brain-resident microglia, which develop during
embryogenesis (Huber et al., 2013; London, Cohen and Schwartz, 2013;
Ginhoux and Prinz, 2015). Within this population, tissue-infiltrating
monocytes can be further characterized by their expression of Ly6C+;
monocytes positive for this marker are able to migrate into the brain
parenchyma and convert into macrophages that are capable of parti-
cipating in antigen-presentation (Gordon and Taylor, 2005; Jakubzick
et al., 2017). These studies collectively suggest an infiltration of
monocytes into the CNS after GW pesticide exposure. These data sug-
gest a cross-talk between astroglia and peripheral adaptive immune
cells in promoting neuroinflammation, which is further supported by
our studies showing activation of NFκB-mediated inflammatory sig-
naling pathways that may be downstream of CCL2-CCR2- and CX3CR1-
CX3CL1 ligation, among other pro-inflammatory receptor systems in
the brain (Bose and Cho, 2013; Sheridan and Murphy, 2013; Ferretti,
Pistoia and Corcione, 2014; Montague et al., 2018). These studies also
suggest further examination of these co-stimulatory pathways for the
pathogenesis of the CNS pathology of GWI.
5. Conclusions
These explorative studies provide strong evidence that in our
PB+PER mouse model of GWI, PER metabolite 3-PBA haptenated
proteins and promoted adaptive immune responses. We also observe
autoantibodies against 3-PBA-haptenated proteins in PB+PER exposed
mice and in veterans with GWI. While the exact mechanisms associated
with these aberrant autoimmune responses and their effects on the CNS
pathology of GWI remain to be elucidated, the work presented herein
suggests a cross-talk between the brain immune cells and peripheral
adaptive immune cells, which may ultimately promote the entry of
peripheral immune cells into the brain and promote neuroinflammatory
responses. We anticipate that these studies will help guide future de-
velopment of biomarkers and therapies for the CNS pathology of GWI.
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